You are viewing: US Body Composition Analyzers Market analysis

The US Body Composition Analyzers Market was valued at $149.6 Million in 2024 and projected to reach to $237.3 Million by 2029, representing a compound annual growth rate of 9.7%. The US body composition analyzers market is positioned for sustained expansion through 2029, fueled by heightened consumer awareness of metabolic health and the growing prevalence of lifestyle-related diseases.

US Body Composition Analyzers Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Body Composition Analyzers Market Trends and Insights

  • This expansion reflects the US healthcare sector's increasing focus on preventive care and personalized health monitoring.
  • The US market is driven by rising obesity rates, growing adoption of fitness tracking technologies, and heightened consumer awareness of metabolic health metrics across clinical and wellness settings. In the US, body composition analyzers are becoming integral to clinical diagnostics, sports medicine, and fitness facilities.
  • The US market benefits from advanced healthcare infrastructure, significant investment in medical device innovation, and strong consumer spending on health and wellness.
  • Between 2024 and 2029, the US is expected to see accelerated adoption across hospitals, diagnostic centers, and commercial fitness establishments, supported by reimbursement improvements and technological advancements in non-invasive measurement techniques..

Key Market Statistics

  • CAGR (2024-2029) 9.7% CAGR
  • Market Size, 2024 ~USD 149.6 Million
  • Forecast, 2029 ~USD 237.3 Million
  • Country US

US Body Composition Analyzers Market Overview

Market Valuation :

The US body composition analyzers market is valued at $149.6 million in 2024, with strong growth trajectory reaching $237.3 million by 2029, representing a 9.7% CAGR.

Obesity Crisis Driver :

Rising obesity rates across the US population are accelerating demand for body composition analysis tools, as healthcare providers and individuals seek precise metrics for weight management and metabolic health monitoring.

Technology Adoption :

Increasing integration of body composition analyzers with wearable devices and mobile health platforms is transforming how Americans track fitness progress and health metrics in real-time.

Preventive Healthcare Shift :

US healthcare sector's pivot toward preventive care and personalized medicine is driving adoption of body composition analyzers in clinical settings, fitness centers, and home health monitoring applications.

US Body Composition Analyzers Market Dynamics

  • Healthcare providers are increasingly incorporating these devices into preventive care protocols, while fitness facilities and wellness centers expand their technological offerings to meet consumer demand for detailed health insights. Government health initiatives addressing obesity and chronic disease prevention are expected to further accelerate market penetration.
  • The convergence of artificial intelligence, cloud-based analytics, and consumer-grade devices will democratize access to body composition analysis, making advanced health monitoring accessible beyond traditional clinical environments and driving market growth across diverse demographic segments..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US body composition analyzers market is valued at $149.6 million in 2024 and will reach $237.3 million by 2029, representing a 9.7% CAGR.
    • The US market is driven by rising obesity prevalence, increased preventive healthcare spending, and growing consumer demand for personalized health metrics.
    • In the US, adoption is accelerating across clinical settings, sports medicine facilities, and commercial fitness centers due to technological improvements and reimbursement support.
    • The US represents a mature, high-value market with strong infrastructure and innovation capacity, positioning it as a key growth engine for body composition analyzer manufacturers.

    Body Composition Analyzers Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment E-COMMERCE (Distribution Channel)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.3% from 2024 to 2029
    Largest Segment BIOIMPEDANCE ANALYZERS (Product)
    Market Size Base Year (Billions) ~USD 0.77 (2024)
    Revenue Forecast (Billions) ~USD 1.2 (2029)
    Segments Covered Product, Type, Modality, Usage Type, Application, Distribution Channel, End User

    US Body Composition Analyzers Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product

    • Air Displacement Plethysmography Equipment
    • Bioimpedance Analyzers
    • Dual-Energy X-Ray Absorptiometry Equipment
    • Hydrostatic Weighing Equipment
    • Skinfold Calipers

    By Type

    • Dual-Frequency Bioimpedance Analyzers
    • Multi-Frequency Bioimpedance Analyzers
    • Single-Frequency Bioimpedance Analyzers

    By Modality

    • Portable Body Composition Analyzers
    • Stationary/Benchtop Body Composition Analyzers

    By Usage Type

    • Consumer-Grade Body Composition Analyzers
    • Professional-Grade Body Composition Analyzers

    By Application

    • Segmental Body Measurement
    • Whole-Body Measurement

    By Distribution Channel

    • E-Commerce
    • Offline/Retail Stores

    By End User

    • Academic & Research Centers
    • Fitness Clubs And Wellness Centers
    • Home Users
    • Hospitals And Clinics

    US: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH CENTERS18.219.520.922.524.226.128.130.47.7
    FITNESS CLUBS AND WELLNESS CENTERS8290.199.2109.2120.4132.8146.7162.210.3
    HOME USERS45.148.752.656.961.766.872.578.78.4
    HOSPITALS AND CLINICS78.585.292.6100.7109.5119.2129.9141.78.9
    TOTAL223.7243.5265.3289.3315.8344.9377.1413.19.3

    Target Audience

    • Medical Device Manufacturers : Manufacturers need US market data to assess market entry feasibility, competitive positioning, and revenue forecasting for body composition analyzer products in the American healthcare ecosystem.
    • Healthcare Providers & Hospitals : Hospital systems and clinical providers require market insights to justify capital investments in body composition analysis equipment and understand adoption trends among peer institutions across the US.
    • Fitness & Wellness Operators : Gym chains and wellness centers need US-specific market intelligence to evaluate technology investments, understand consumer demand for body composition services, and benchmark against industry standards.
    • Investment & Private Equity Firms : Investors evaluating opportunities in US healthcare technology require validated market sizing, growth projections, and competitive analysis to support due diligence and portfolio decisions.
    • Health Insurance Companies : Insurers need market data to assess reimbursement strategies, understand preventive care technology adoption, and evaluate the clinical and economic value of body composition analysis in the US market.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Confirm the US market opportunity with precise valuation data ($149.6M in 2024) and verified CAGR projections (9.7%) to support investment decisions and business planning in the American healthcare technology sector.
    • Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, key players, and market positioning strategies tailored to American healthcare regulations, consumer preferences, and distribution channels.
    • Demand Driver Analysis : Identify and quantify US-specific growth catalysts including obesity epidemiology, preventive care adoption rates, fitness industry trends, and consumer health consciousness to inform product development and marketing strategies.
    • Regulatory & Reimbursement Insights : Access critical information on FDA approval pathways, insurance reimbursement policies, and healthcare compliance requirements specific to the US market for body composition analysis devices.
    • Strategic Market Segmentation : Leverage detailed US market segmentation by end-user (hospitals, clinics, fitness centers, home use), technology type, and geographic regions to identify high-potential niches and expansion opportunities.

    Frequently asked questions

    What is the current size of the US body composition analyzers market?

    The US body composition analyzers market was valued at $149.6 million in 2024 and is projected to grow to $237.3 million by 2029.

    What is the expected growth rate for body composition analyzers in the US?

    The US market is expected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2029.

    What are the primary drivers of growth in the US body composition analyzers market?

    Key drivers in the US include rising obesity rates, increased focus on preventive healthcare, growing fitness and wellness trends, technological advancements, and improved insurance reimbursement policies.

    Which sectors are adopting body composition analyzers most rapidly in the US?

    The US is seeing rapid adoption in clinical diagnostics, hospitals, sports medicine facilities, fitness centers, and wellness programs, driven by both healthcare providers and fitness-conscious consumers.

    How does the US market compare to global trends in body composition analyzers?

    The US market growth rate of 9.7% slightly exceeds the global CAGR of 9.3%, reflecting the US's advanced healthcare infrastructure, high consumer spending on wellness, and strong technological innovation ecosystem.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the body composition analyzers market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the body composition analyzers market. The primary sources from the demand side include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights into key industry trends & key market dynamics.

    Breakdown of Primary Interviews

    A breakdown of the primary respondents for the body composition analyzers market (supply side) is provided below:

    Body Composition Analyzers Market 
 Size, and Share

    Note: Others include sales, marketing, and product managers.
    Companies are classified into tiers based on their total revenue.
    As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In this report, the global body composition analyzers market size was arrived at by using the revenue share analysis of leading players. For this purpose, key players were identified, and their revenues from the body composition analyzer business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

    To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involves the following steps:

    • Generating a list of major global players operating in the body composition analyzers market
    • Mapping annual revenues generated by major global players from the body composition analyzers segment (or nearest reported business unit/service category)
    • Revenue mapping of key players to cover a major share of the global market as of 2025
    • Extrapolating the global value of the market

    Top-Down and Bottom-Up Approach

    Body Composition Analyzers Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the overall market size from the market size estimation process explained above, the global body composition analyzers market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market was validated using both top-down and bottom-up approaches.

    Market Definition

    Body composition analyzers consist of devices and systems that quantitatively measure a person’s body composition, which includes different parameters such as body fat mass, percentage of body fat, body muscle mass, lean mass, total body water amount, bone mass, and visceral fat. To estimate or assess body composition, analyzers employ various technologies such as bioelectrical impedance analysis (BIA), dual-energy X-ray absorptiometry (DEXA/DXA), skinfold measurement, air displacement plethysmography, and hydrostatic weighing.

    Key Stakeholders

    • Body composition analyzer manufacturing companies
    • Original equipment manufacturing companies
    • Body composition analyzer Suppliers and distributors
    • Healthcare service providers
    • Health insurance payers
    • Government bodies/municipal corporations
    • Regulatory bodies
    • Medical research institutes
    • Business research and consulting service providers
    • Venture capitalists
    • Market research and consulting firms

    Report Objectives

    • To describe and forecast the global body composition analyzers market, by product, usage type, modality, application, end user, and region, in terms of value
    • To forecast the global body composition analyzers market, by product, in terms of volume
    • To forecast the size of the market segments concerning five main regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, in terms of value
    • To provide detailed information regarding the major factors influencing the market growth
      (such as drivers, restraints, opportunities, and challenges) along with the current trends
    • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
    • To analyze the opportunities in the global market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile the key players and analyze their market shares and core competencies
    • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, expansions, strategic alliances, and acquisitions, in the global market
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global body composition analyzers market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top twelve companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to 10)

    Geographic Analysis

    • Further breakdown of the Rest of Europe’s body composition analyzers market into Russia, Finland, Switzerland, Turkey, the Czech Republic, the Netherlands, Norway, Poland, Portugal, Romania, Estonia, Austria, Belgium
    • Further breakdown of the Rest of Asia Pacific’s body composition analyzers market into Taiwan, New Zealand, and Sri Lanka
    • Further breakdown of the Rest of Latin America’s body composition analyzers market into Uruguay, Costa Rica, Bolivia, Venezuela, and Paraguay

     

    Get the Full Body Composition Analyzers Market Report

    Full forecast, segment splits, and company analysis for all Body Composition Analyzers Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status